CHICAGO, IL USA (UroToday.com) - Presented by Scott T. Tagawa,1 Edwin M. Posadas,2 Justine Bruce,3 Emerson A. Lim,4 Daniel P. Petrylak,5 Weimin Peng,6 Scott Maul,6 Johan W. Smit,7 NamPhuong Tran,6 and David M. Nanus1 at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting - May 30 - June 3, 2014 - Chicago, Illinois USA
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Click HERE to listen to an interview with Scott T. Tagawa, MD, one of the authors of this study
1Weill Cornell Medical College, New York, NY USA
2Cedars-Sinai Medical Center, Los Angeles, CA USA
3University of Wisconsin School of Medicine and Public Health, Madison, WI USA
4Columbia University Medical Center, New York, NY USA
5Yale Cancer Center, New Haven, CT USA
6Janssen Research & Development, Los Angeles, CA USA
7Janssen Research & Development, Beerse, Belgium